Patents by Inventor Philippe Maincent

Philippe Maincent has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical dosage forms for the release of active compounds
    Patent number: 8361509
    Abstract: Pharmaceutical form containing at least an active compound and a polymeric matrix, wherein said polymeric matrix comprises at least one polymer of cationic nature and at least one biodegradable polymer, process for the preparation thereof, pharmaceutical formulations comprising said pharmaceutical form, and their uses. The pharmaceutical form provides enhanced absorption of active compounds across the mucosa.
    Type: Grant
    Filed: January 23, 2012
    Date of Patent: January 29, 2013
    Assignee: Laboratorios Farmacéticos Rovi, S.A.
    Inventors: Iván López-Belmonte Encina, Ibon Gutierro Aduriz, Philippe Maincent
  • Pharmaceutical forms for the release of active compounds
    Patent number: 8257744
    Abstract: Pharmaceutical form containing at least an active compound and a polymeric matrix, wherein said polymeric matrix comprises at least one polymer of cationic nature and at least one biodegradable polymer, process for the preparation thereof, pharmaceutical formulations comprising said pharmaceutical form, and their uses. The pharmaceutical form provides enhanced absorption of active compounds across the mucosa.
    Type: Grant
    Filed: May 13, 2010
    Date of Patent: September 4, 2012
    Assignee: Laboratorios Farmacéuticos Rovi, S.A.
    Inventors: Ivan Lopez-Belmonte Encina, Ibon Gutierro Aduriz, Philippe Maincent
  • Pharmaceutical Dosage Forms for the Release of Active Compounds
    Publication number: 20120189698
    Abstract: Pharmaceutical form containing at least an active compound and a polymeric matrix, wherein said polymeric matrix comprises at least one polymer of cationic nature and at least one biodegradable polymer, process for the preparation thereof, pharmaceutical formulations comprising said pharmaceutical form, and their uses. The pharmaceutical form provides enhanced absorption of active compounds across the mucosa.
    Type: Application
    Filed: January 23, 2012
    Publication date: July 26, 2012
    Applicant: LABORATORIOS FARMACEUTICOS ROVI S.A.
    Inventors: Iván LÓPEZ-BELMONTE ENCINA, Ibon GUTIERRO ADURIZ, Philippe MAINCENT
  • Particulate vectors for improving oral absorption of active principles
    Patent number: 8052998
    Abstract: The invention concerns particulate vectors designed to improve oral absorption of active principles, characterized in that they consist of a polymeric matrix comprising at least a biodegradable polymer associated with at least a polycationic polymer.
    Type: Grant
    Filed: July 5, 2001
    Date of Patent: November 8, 2011
    Assignee: Laboratorios Farmaceuticos Roui, S.A.
    Inventors: Philippe Maincent, Nathalie Ubrich, Claude Vigneron
  • Pharmaceutical Forms for the Release of Active Compounds
    Publication number: 20100316722
    Abstract: Pharmaceutical form containing at least an active compound and a polymeric matrix, wherein said polymeric matrix comprises at least one polymer of cationic nature and at least one biodegradable polymer, process for the preparation thereof, pharmaceutical formulations comprising said pharmaceutical form, and their uses. The pharmaceutical form provides enhanced absorption of active compounds across the mucosa.
    Type: Application
    Filed: May 13, 2010
    Publication date: December 16, 2010
    Applicant: LABORATORIOS FARMACEUTICOS ROVI S.A.
    Inventors: Iván LOPEZ-BELMONTE ENCINA, Ibon GUTIERRO ADURIZ, Philippe MAINCENT
  • Particulate vectors for improving oral absorption of active principles
    Publication number: 20050013866
    Abstract: The invention concerns particulate vectors designed to improve oral absorption of active principles, characterised in that they consist of a polymeric matrix comprising at least a biodegradable polymer associated with at least a polycationic polymer.
    Type: Application
    Filed: July 5, 2001
    Publication date: January 20, 2005
    Inventors: Philippe Maincent, Nathalie Ubrich, Claude Vigneron
  • Ophthalmic product
    Patent number: 5308624
    Abstract: Ophthalmic product comprising nanocapsules, process for preparing it and application of the nanocapsules.The present invention relates to an ophthalmic product comprising nanocapsules, characterized by a central core of lipid nature surrounded by a polymeric membrane capable of adhering to biological tissues.The present invention also relates to its preparation and to the application of the nanocapsules for ophthalmic use.
    Type: Grant
    Filed: March 29, 1991
    Date of Patent: May 3, 1994
    Assignee: Laboratorios Cusi, S.A.
    Inventors: Philippe Maincent, Laurent Marchal-Heussler, Daniel Sirdat